| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/14/2013 | CN102210848B Medicament for treating skin disease, and preparation method thereof |
| 08/14/2013 | CN102173987B New manchurian walnut bark acid and derivatives thereof, and preparation methods and medical application thereof |
| 08/14/2013 | CN102114004B Double-layer sustained-release nifedipine tablet and preparation method thereof |
| 08/14/2013 | CN102105134B Stable injectable oil-in-water docetaxel nanoemulsion |
| 08/14/2013 | CN102091272B Black plaster product for bone fracture and preparation method thereof |
| 08/14/2013 | CN102085197B Venlafaxine slow-release preparation and preparation method thereof |
| 08/14/2013 | CN102026623B Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 08/14/2013 | CN101984745B Drug cores for sustained release of therapeutic agents |
| 08/14/2013 | CN101983054B Orally rapidly disintegrating tablet comprising imidafenacin |
| 08/14/2013 | CN101966157B Decitabine sustained release microsphere and preparation method thereof |
| 08/14/2013 | CN101909604B Method of treating dysglycemia and glucose excursions |
| 08/14/2013 | CN101897754B Preparation method of polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation |
| 08/14/2013 | CN101879202B Application of Java brucea fruit oil emulsion injection to anticancer aspect |
| 08/14/2013 | CN101808623B Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| 08/14/2013 | CN101695501B Chitosan entrapment body of nano-scale arsenous acid and manufacturing method thereof |
| 08/14/2013 | CN101524433B Analytical method of gynecological inflammation clearance tablet |
| 08/14/2013 | CN101516354B Multi-core solid dosage form comprising transparent coating between said cores |
| 08/14/2013 | CN101467985B Bisoprolol fumarate dispersible tablet and preparation method thereof |
| 08/14/2013 | CN101283991B Orally-disintegrating tablet and manufacturing method thereof |
| 08/13/2013 | US8507606 Biocomposite materials and methods for making the same |
| 08/13/2013 | US8507603 Solvent dispersion of composite resin and uses thereof |
| 08/13/2013 | US8507563 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same |
| 08/13/2013 | US8507556 Fluorescent particles comprising nanoscale ZnO layer and exhibiting cell-specific toxicity |
| 08/13/2013 | US8507527 Method for stabilizing anti-dementia drug |
| 08/13/2013 | US8507462 Compositions and uses thereof |
| 08/13/2013 | US8507454 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 08/13/2013 | US8507437 Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same |
| 08/13/2013 | US8507430 Methods for administering FGF18 |
| 08/13/2013 | US8507009 Colonic purgative composition with soluble binding agent |
| 08/13/2013 | US8507006 Porous particles loaded with cosmetically or pharmaceutically active compounds |
| 08/13/2013 | US8507005 Particulates of a CRTH2 antagonist |
| 08/13/2013 | US8507004 Use of MgO doped with a divalent or trivalent metal cation for removing arsenic from water |
| 08/13/2013 | US8507003 Compressed tablets comprising microcapsules with modified release |
| 08/13/2013 | US8507002 Hydrogel composition and methods for making the same |
| 08/13/2013 | US8507001 Dosage forms for tamper prone therapeutic agents |
| 08/13/2013 | US8507000 Controlled release formulation of erythromycin derivatives |
| 08/13/2013 | US8506999 Pharmaceutical tablets comprising a plurality of segments |
| 08/13/2013 | US8506998 Pharmaceutical formulation |
| 08/13/2013 | US8506997 Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus |
| 08/13/2013 | US8506996 Therapeutic delivery system |
| 08/13/2013 | US8506995 Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
| 08/13/2013 | US8506994 Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
| 08/13/2013 | US8506993 Compositions and methods for making and using multifunctional polymerized liposomes |
| 08/13/2013 | US8506992 Percutaneous absorption-type pharmaceutical preparations |
| 08/13/2013 | US8506991 Nicotine transdermal preparation and production method thereof |
| 08/13/2013 | US8506990 Local administration of gallium compositions to treat pain |
| 08/13/2013 | US8506989 Preparation comprising a creatine component, method for the production thereof, and the use thereof |
| 08/13/2013 | US8506987 Ocular implant made by a double extrusion process |
| 08/13/2013 | US8506986 Associated with diabetes; implanting an alpha-2 adrenergic receptor agonist, such as brimonidine, associated with a biodegradable polymer matrix; hypotensive agents, antiischemic agents; glaucoma |
| 08/13/2013 | US8506981 Compositions and their use in bone healing |
| 08/13/2013 | US8506975 Cosmetic compositions utilizing a silicone-free hydrocarbon complex |
| 08/13/2013 | US8506974 Silicon-free hydrocarbons providing aesthetic volatility |
| 08/13/2013 | US8506973 Injectable anticancer composition for local administration containing hydroxychloroquine |
| 08/13/2013 | US8506972 Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions |
| 08/13/2013 | US8506940 Aqueous compositions comprising vesicles having certain vesicle permeability |
| 08/13/2013 | US8506936 Stabilized nicotine chewing gum |
| 08/13/2013 | US8506935 Respiratory drug condensation aerosols and methods of making and using them |
| 08/13/2013 | US8506859 Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene |
| 08/13/2013 | CA2592474C Prostaglandin f2.alpha. derivative-containing product |
| 08/13/2013 | CA2570976C Methods of treatment of endobronchial infections |
| 08/13/2013 | CA2567830C Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| 08/13/2013 | CA2563593C Paper tissue with high lotion transferability |
| 08/13/2013 | CA2542450C Dry powder formulations |
| 08/13/2013 | CA2530113C Bioerodible sustained release drug delivery systems |
| 08/13/2013 | CA2526454C Gel-assisted production of small particles |
| 08/13/2013 | CA2512738C Method for producing an oral pharmaceutical form with immediate disintegration and active ingredient release |
| 08/13/2013 | CA2509043C Method of preparing biologically active formulations |
| 08/13/2013 | CA2504021C Compositions and methods for transdermal oxybutynin therapy |
| 08/13/2013 | CA2494489C Method of making microcapsules utilizing a fluid ejector |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2330741C Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 08/13/2013 | CA2312512C Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets |
| 08/08/2013 | WO2013116822A1 Methods and compositions for treating gastric disorders |
| 08/08/2013 | WO2013116738A1 Drug formulations |
| 08/08/2013 | WO2013116691A1 Methods for improving muscle strength |
| 08/08/2013 | WO2013116339A1 High potency formulations of vx-950 |
| 08/08/2013 | WO2013116150A1 Spinal fusion system for osteoporotic vertebrae |
| 08/08/2013 | WO2013116061A1 Insertion and removal methods and apparatus for therapeutic devices |
| 08/08/2013 | WO2013115965A1 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 08/08/2013 | WO2013115844A1 Compositions and methods for treatment of glaucoma |
| 08/08/2013 | WO2013115759A1 Topical medications for controlling epidermal symptoms |
| 08/08/2013 | WO2013115746A1 A production method for (effervescent) pharmaceutical compositions comprising an alpha - glucosidase inhibitor (miglitol) and metformin |
| 08/08/2013 | WO2013115745A1 A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin) |
| 08/08/2013 | WO2013115744A1 A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin) |
| 08/08/2013 | WO2013115743A1 Effervescent tablet formulations comprising the combination of voglibose and metformin |
| 08/08/2013 | WO2013115742A1 Pharmaceutical composition comprising alpha-glucosidase inhibitor |
| 08/08/2013 | WO2013115741A1 Pharmaceutical compositions comprising alpha-glucosidase inhibitor |
| 08/08/2013 | WO2013115740A1 Synergisctic combination comprising a meglitinide derivative and lipoic acid |
| 08/08/2013 | WO2013115739A1 Production method for formulations comprising comprising nateglinide and lipoic acid |
| 08/08/2013 | WO2013115738A1 Micronized acarbose |
| 08/08/2013 | WO2013114418A1 Transdermal administration of prostaglandin e1 for the treatment of ocular ischemia |
| 08/08/2013 | WO2013114416A1 Lyophilized tablets of escitalopram oxalate for sublingual administration |
| 08/08/2013 | WO2013114413A1 Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy |
| 08/08/2013 | WO2013114410A1 A composition and use thereof in the treatment of anal rhagades |
| 08/08/2013 | WO2013114390A1 Gastro retentive drug delivery system of calcium supplements |
| 08/08/2013 | WO2013114389A1 Process for preparing solid oral formulations comprising low dose of entecavir |
| 08/08/2013 | WO2013114377A1 Stable liposomes for drug delivery |
| 08/08/2013 | WO2013114369A1 Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same |
| 08/08/2013 | WO2013114283A1 Gastroretentive tablets |
| 08/08/2013 | WO2013114281A1 Pregabalin gr tablets |